Literature DB >> 23420484

Sex and risk of hip implant failure: assessing total hip arthroplasty outcomes in the United States.

Maria C S Inacio1, Christopher F Ake, Elizabeth W Paxton, Monti Khatod, Cunlin Wang, Thomas P Gross, Ronald G Kaczmarek, Danica Marinac-Dabic, Art Sedrakyan.   

Abstract

IMPORTANCE: The role of sex in relationship to implant failure after total hip arthroplasty (THA) is important for patient management and device innovation.
OBJECTIVE: To evaluate the association of sex with short-term risk of THA revision after adjusting for patient, implant, surgery, surgeon, and hospital confounders. DESIGN AND
SETTING: A prospective cohort of patients enrolled in a total joint replacement registry from April 1, 2001, through December 31, 2010. PARTICIPANTS: Patients undergoing primary, elective, unilateral THA. MAIN OUTCOME MEASURES: Failure of THA, defined as revision procedure for (1) any reason, (2) septic reason, or (3) aseptic reason after the index procedure.
RESULTS: A total of 35,140 THAs with 3.0 years of median follow-up were identified. Women constituted 57.5% of the study sample, and the mean (SD) patient age was 65.7 (11.6) years. A higher proportion of women received 28-mm femoral heads (28.2% vs 13.1%) and had metal on highly cross-linked polyethylene-bearing surfaces (60.6% vs 53.7%) than men. Men had a higher proportion of 36-mm or larger heads (55.4% vs 32.8%) and metal on metal-bearing surfaces (19.4% vs 9.6%). At 5-year follow-up, implant survival was 97.4% (95% CI, 97.2%-97.6%). Device survival for men (97.7%; 95% CI, 97.4%-98.0%) vs women (97.1%; 95% CI, 96.8%-97.4%) was significantly different (P = .01). After adjustments, the hazards ratios for women were 1.29 (95% CI, 1.11-1.51) for all-cause revision, 1.32 (95% CI, 1.10-1.58) for aseptic revision, and 1.17 (95% CI, 0.81-1.68) for septic revision.
CONCLUSIONS: After considering patient-, surgery-, surgeon-, volume-, and implant-specific risk factors, women had a 29% higher risk of implant failure than men after THA in this community-based sample.

Entities:  

Mesh:

Year:  2013        PMID: 23420484     DOI: 10.1001/jamainternmed.2013.3271

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN: 2168-6106            Impact factor:   21.873


  19 in total

1.  Enrollment and monitoring of women in post-approval studies for medical devices mandated by the Food and Drug Administration.

Authors:  Ellen Pinnow; Naomi Herz; Nilsa Loyo-Berrios; Michelle Tarver
Journal:  J Womens Health (Larchmt)       Date:  2014-01-09       Impact factor: 2.681

Review 2.  Contributions of human tissue analysis to understanding the mechanisms of loosening and osteolysis in total hip replacement.

Authors:  Jiri Gallo; Jana Vaculova; Stuart B Goodman; Yrjö T Konttinen; Jacob P Thyssen
Journal:  Acta Biomater       Date:  2014-02-10       Impact factor: 8.947

Review 3.  Why are sex and gender important to basic physiology and translational and individualized medicine?

Authors:  Virginia M Miller
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-01-10       Impact factor: 4.733

4.  Clinical Factors, Disease Parameters, and Molecular Therapies Affecting Osseointegration of Orthopedic Implants.

Authors:  Hilal Maradit Kremers; Eric A Lewallen; Andre J van Wijnen; David G Lewallen
Journal:  Curr Mol Biol Rep       Date:  2016-06-29

Review 5.  What Host Factors Affect Aseptic Loosening After THA and TKA?

Authors:  Jeffrey J Cherian; Julio J Jauregui; Samik Banerjee; Todd Pierce; Michael A Mont
Journal:  Clin Orthop Relat Res       Date:  2015-02-26       Impact factor: 4.176

6.  Risk factors for early revision after total hip arthroplasty.

Authors:  Christopher J Dy; Kevin J Bozic; Ting Jung Pan; Timothy M Wright; Douglas E Padgett; Stephen Lyman
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-06       Impact factor: 4.794

7.  Pregnancy Does Not Adversely Affect Postoperative Pain and Function in Women With Total Hip Arthroplasty.

Authors:  Lindsay Lally; Lisa A Mandl; Wei-Ti Huang; Susan M Goodman
Journal:  J Clin Rheumatol       Date:  2015-09       Impact factor: 3.517

8.  Diversity in Medical Device Clinical Trials: Do We Know What Works for Which Patients?

Authors:  Stephanie R Fox-Rawlings; Laura B Gottschalk; Laurén A Doamekpor; Diana M Zuckerman
Journal:  Milbank Q       Date:  2018-09       Impact factor: 4.911

9.  Aseptic Loosening after THA and TKA - Do gender, tobacco use and BMI have an impact on implant survival time?

Authors:  Erik Schiffner; David Latz; Simon Thelen; Jan P Grassmann; Alfred Karbowski; Joachim Windolf; Pascal Jungbluth; Johannes Schneppendahl
Journal:  J Orthop       Date:  2019-04-08

10.  [Establishment of artificial joint aseptic loosening mouse model by cobalt-chromium particles stimulation].

Authors:  Shengyuan Jiang; Dan Li; Jianhao Jiang; Shangyou Yang; Shuye Yang
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2020-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.